164 related articles for article (PubMed ID: 3020748)
1. Increased serum beta 2 microglobulin during rejection, cyclosporine-induced nephrotoxicity, and cytomegalovirus infection in renal transplant recipients.
Bäckman L; Ringdén O; Björkhem I; Lindbäck B
Transplantation; 1986 Oct; 42(4):368-71. PubMed ID: 3020748
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of alpha-1 microglobulin in recipients of renal allografts.
Bäckman L; Ringdén O; Dati F
Transpl Int; 1989 Apr; 2(1):23-6. PubMed ID: 2475119
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of serum neopterin levels in renal transplant recipients: increased values during impaired renal function and cytomegalovirus infection.
Bäckman L; Ringdén O; Björkhem I
Nephron; 1987; 46(3):319-22. PubMed ID: 2819750
[TBL] [Abstract][Full Text] [Related]
4. [Serum beta 2 microglobulin (beta 2M) following renal transplantation].
Pacheco-Silva A; Nishida SK; Silva MS; Ramos OL; Azjen H; Pereira AB
Rev Assoc Med Bras (1992); 1994; 40(3):172-8. PubMed ID: 7787867
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A.
Duraj FF; Bäckman L; Dati F; Ringdén O
Transpl Int; 1991 Sep; 4(3):146-50. PubMed ID: 1720317
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of serum beta 2 microglobulin and neopterin levels in renal transplant recipients: increased values during impaired renal function and cytomegalovirus infection.
Bäckman L; Ringdén O; Björkhem I
Transplant Proc; 1988 Jun; 20(3):410-2. PubMed ID: 2837852
[No Abstract] [Full Text] [Related]
7. Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients.
Prischl F; Gremmel F; Schwabe M; Schindler J; Balcke P; Kopsa H; Pinter G; Schwarzmeier J; Zazgornik J
Nephron; 1989; 51(3):330-7. PubMed ID: 2645532
[TBL] [Abstract][Full Text] [Related]
8. beta-2-microglobulin. Quantitation by rocket immunoelectrophoresis and evaluation of serum levels in renal transplant patients.
Barnes RM; Alexander LC
Transplantation; 1983 Jun; 35(6):552-5. PubMed ID: 6191415
[TBL] [Abstract][Full Text] [Related]
9. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
10. Serum beta 2-microglobulin before and after renal and heart allotransplantation and in infection.
Korcáková L; Svobodová J; Sedlácková E; Kaslík J; Kaslíková J; Horák J; Fabián J; Kocandrle V
Czech Med; 1989; 12(3):158-61. PubMed ID: 2553359
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating concentrations of interleukin 2 receptor during rejection episodes in heart- or kidney-transplant recipients.
Zucchelli GC; Clerico A; De Maria R; Carmellini M; Di Stefano R; Masini S; Pilo A; Donato L
Clin Chem; 1990 Dec; 36(12):2106-9. PubMed ID: 2253354
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study.
Raasveld MH; Bloemena E; Wilmink JM; Surachno S; Schellekens PT; ten Berge RJ
Transpl Int; 1993 Mar; 6(2):89-94. PubMed ID: 8383495
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.
Maury CP; Teppo AM
Clin Nephrol; 1984 Dec; 22(6):284-92. PubMed ID: 6441659
[TBL] [Abstract][Full Text] [Related]
14. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.
Yoshimura N; Oka T; Kahan BD
Transplantation; 1991 Jan; 51(1):172-6. PubMed ID: 1987687
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between renal allograft rejection and cyclosporine toxicity: a clinicopathological study.
Alexopoulos E; Leontsini M; Daniilidis M; Sakellariou G; Visvardis G; Papadimitriou M
Am J Kidney Dis; 1991 Jul; 18(1):108-15. PubMed ID: 2063842
[TBL] [Abstract][Full Text] [Related]
16. B2-microglobulin and renal graft rejection: relationship to plasma creatinine during stable transplant function and graft rejection.
Barnes RM; Alexander LC; West CR
Transplant Proc; 1984 Dec; 16(6):1613-5. PubMed ID: 6390875
[No Abstract] [Full Text] [Related]
17. Renal excretion and cyst accumulation of beta 2microglobulin in polycystic kidney disease.
Birenboim N; Donoso VS; Huseman RA; Grantham JJ
Kidney Int; 1987 Jan; 31(1):85-92. PubMed ID: 3550218
[TBL] [Abstract][Full Text] [Related]
18. Serum and urine beta-2-microglobulin and lysozyme concentrations in transplant rejection.
Roberts JL; Lewis EJ
Proc Clin Dial Transplant Forum; 1979; 9():145-9. PubMed ID: 95329
[TBL] [Abstract][Full Text] [Related]
19. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.
Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O
N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195
[TBL] [Abstract][Full Text] [Related]
20. Beta-2-microglobulin in the assessment of renal function of the transplanted kidney.
Woo KT; Lee EJ; Lau YK; Lim CH
Nephron; 1985; 39(3):223-7. PubMed ID: 3883210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
